抗病毒纳米医学:优势,机制和先进疗法
Yicheng Pu1, Chuanda Zhu2, Jun Liao1
1Institute of Systems Biomedicine, Beijing Key Laboratory of Tumor Systems Biology, School of Basic Medical Sciences, Peking University, Beijing 100191, China.
Bioactive materials
|June 18, 2025
概括
新型纳米药物提供了针对病毒感染的创新策略,克服了传统抗病毒药物的局限性. 本综述探讨了先进的纳米抗病毒药物及其对抗未来病毒威胁的潜力.
科学领域:
- 病毒学 病毒学
- 纳米技术 纳米技术
- 纳米医学是一种纳米医学.
背景情况:
- 新兴的病毒病原体和有限的传统抗病毒疗法需要新的策略.
- 纳米药物在抗病毒应用中比小分子药物具有独特的优势.
研究的目的:
- 审查病毒感染和抗病毒纳米药物的作用.
- 系统地对纳米药物机制进行分类,并强调它们的优势.
- 讨论对抗病毒纳米疗法的转化挑战和未来方向.
主要方法:
- 对抗病毒纳米药物的当前研究进行系统审查.
- 纳米药物作用机制的分类.
- 对纳米药物与小分子药物的比较分析.
主要成果:
- 纳米药物具有独特的属性和优势,包括有针对性的输送和增强的疗效.
- 先进的纳米抗病毒药物,如纳米光敏剂,仿生诱,PROTAC降解剂和基因沉默平台显示出有前途.
- 开发了一个整合纳米药物机制碎片化知识的框架.
结论:
- 抗病毒纳米药物代表了对抗病毒感染的变革性方法.
- 跨学科的合作对于解决翻译挑战和加速下一代抗病毒药物的开发至关重要.
- 本综述提供了一个综合的概述,以激励未来的病毒学,纳米技术和精密医学研究.
相关概念视频
Microorganisms in Medicine and Therapeutics
382
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
382
siRNA - Small Interfering RNAs
17.0K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.0K
Retrovirus Life Cycles
47.0K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
47.0K
Subviral Agents
130
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
130


